Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
The International Liver Transplant Society (ILTS) is a newly formed, dynamic growing organization which was established in 1990 in Berlin comprising about 900 international members from all over the world who belong to a multidisciplinary sector of specialists and healthcare providers, sharing main focus of promoting the ILTS , the advancement of the science and practice of liver transplantation by sharing of clinical and educational experiences and research at an international level. The ILTS provides three main educational activities: a)Annual congress to disseminate current information in liver transplantation; b) Education for trainees and interested health care providers and scientists; c)Publication of proceedings of symposia and congresses.In addition, the ILTS co-sponsors important conferences. The ILTS strives to be the world’s supreme society on all issues related to liver transplantation.
The ILTS was founded with a clear mission of statement emphasizing a multidisciplinary approach, and effective interaction between clinicians, scientists, researchers belonging to all disciplines including liver transplantation. Individuals, who have provided ideas, encouragement and significant assistance in the evolution and formation of the ILTS are Drs. William Merritt, Drs. Ake Grenvik and David Plevak of critical care medicine , Andre DeWolf, David Van Thiel and Michael Sorrell of hepatology and Jorge Estrin of anesthesiology, Drs. Russell Wiesner; Drs. William Wall, John Fung and Robert Gordon from surgery field. The goal is to ,motivate showcasing of basic research findings at the Annual Meeting ,to organize workshops on specific basic science topics and to create a network among the experts.In the past years of existence of this society, many advances in liver transplantation have occurred. Novel anti-viral agents have been developed along with the development of radiographic decompressive procedures for portal hypertension; efforts that define “standard minimal listing criteria” and modeling to predict the expected rate of mortality in order to achieve more rational decision regarding organ allocation; the implementation of new immunosuppressive agents and recent tolerance studies; broader application of living related to split liver transplant technology; concentrating into xenotransplantation, gene therapy and bio artifical liver technology. In addition, liver transplantation has been applied on a worldwide basis, and is currently available in more than 60 countries of all the populated continents. Although many of the objectives that were aspired by the original founding members of the ILTS have been achieved, the current ILTS leadership and its members continues to explore new ideas and concepts. They have partnered with several organizations, including LICAGE, the European Liver Transplant Association (ELTA), the American Society of Anesthesiology and AASLD to support the objectives by co-sponsoring annual meetings and/or conducting liver transplant sessions as part of their meetings.
Read More»The following is the list of scholars from International Liver Transplantation Society who contributed and/or serves as editors for one or more OMICS International journals and conferences